Global $568 Billion Specialty Pharmaceuticals Market to 2026: Leverage the Changing Face of Specialty Pharmacy Industry with Flat World Solutions
DUBLIN, Sept. 10, 2019 /PRNewswire/ -- The "Specialty Pharmaceuticals Market, by Country (US, UK, France, Germany, Italy, Spain, Japan, South Korea), Application, Company, Global Analysis" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Global Specialty Pharmaceuticals Market is expected to be USD 568 Billion by 2026.
Specialty pharmaceuticals are regarded to be a drug molecule that helps in the treatment of particular genetic conditions that have no therapeutic action on the market. Specialty Pharmaceuticals considered to be more targeted drugs than traditional drugs and are also less toxic. Specialty pharmaceutical consists of products like blood-derived, biopharmaceuticals, and complex molecules.
Specialty pharmaceuticals are high cost and complex drugs; the average price per patient per year for specialty medical therapy is about $35,000 to $75,000. Specialty pharmaceutical is used to treat rare diseases such as Hepatitis C, Cancer, Rheumatoid Arthritis, AIDS (Acquired Immunodeficiency Virus Syndrome), Crohn's disease, etc.
Specialty pharmacy is multiplying and becoming a significant factor for health systems and producers across the United States. The FDA approved 21 new molecular entities in the second half of 2018. Out of these products, 12 (57%) are regarded as pharmaceutical specialties based on variables such as indication and designed use population, administrative and tracking considerations, price and/or restricted delivery procedures. In the last five years, the United States spending on specialty drugs has almost doubled.
Oncology, Autoimmune, and Immunology are among the most significant application of global specialty pharmaceutical market
The report studies the market for the following application segments: Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis, and Others. Due to the rising cases of oncology globally, Oncology is the leading application segment in this market place.
Specialty Pharmaceutical Market Share is expected to cross half of the global pharmaceutical market
The global pharmaceutical market is segmented by two types: traditional pharmaceutical and specialty pharmaceutical. At present, traditional pharmaceutical is in the dominating position across the globe, but due to increasing demands of specialty pharmaceutical products, it is anticipated that specialty pharmaceuticals will lead during the forecast period.
Company Analysis
Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals are some of the companies that deal efficiently in the specialty pharmaceuticals business. These companies have been studied thoroughly in the report.
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Global Specialty Pharmaceuticals
4.1 Market
4.2 Specialty Drug Pipeline
5. Market Share - Specialty Pharmaceutical Analysis
5.1 By Country
5.2 By Pharmaceutical Industry
5.3 By Application
6. Global Pharmaceuticals Analysis
6.1 Total Market
6.2 Traditional Pharmaceutical Market
7. Country - Specialty Pharmaceutical
7.1 United States
7.1.1 Market
7.1.2 Specialty Drug Pipeline
7.2 Top 5 European Country
7.3 United Kingdom
7.4 France
7.5 Germany
7.6 Italy
7.7 Spain
7.8 Japan
7.9 South Korea
8. Application - Specialty Pharmaceutical Market
8.1 Oncology
8.2 Autoimmune
8.3 Immunology
8.4 HIV
8.5 Multiple Sclerosis (MS)
8.6 Viral Hepatitis
8.7 Blood Coagulation
8.8 Respiratory
8.9 Osteoporosis
8.10 All Others
9. Market Dynamics
9.1 Growth Drivers
9.1.1 Improving Life Expectancy
9.1.2 Surge in Spending on Medicines
9.1.3 Prevalence of Chronic Disease
9.2 Key Challenges
9.2.1 Abandonment Rates for Specialty Medicines & High R&D Costs
10. Trend and Opportunities
10.1 Trends
10.1.1 Increased Spending on Specialty Pharmacy
10.1.2 A Generic Wave of Specialty Drugs
10.1.3 An Ever-expanding Pipeline of Products
10.1.4 Targeted Therapies to Emerge
10.1.5 Healthcare Reforms to Take Control
10.1.6 Growth of Co-Pay Programs
10.1.7 Medication Therapy Management (MTM) will Advance
10.1.8 Specialty Prescribing to Rise
10.1.9 Real-Time Pharmacy Benefit
10.2 Opportunities
10.2.1 Leverage the Changing Face of Specialty Pharmacy Industry with Flat world Solutions
11. Specialty Pharmacy Mergers and Acquisitions
12. Company Analysis
12.1 Teva Pharmaceutical Industries Ltd
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 CVS Health
12.3 Endo International Specialty Products
12.4 UnitedHealth Group Incorporated
12.5 Recordati Pharmaceuticals Ltd
For more information about this report visit https://www.researchandmarkets.com/r/vhbw1e
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-568-billion-specialty-pharmaceuticals-market-to-2026-leverage-the-changing-face-of-specialty-pharmacy-industry-with-flat-world-solutions-300915411.html
SOURCE Research and Markets
